The quality of Chinese herbal pieces is worrying! How can pharmaceutical companies avoid falling into a vicious circle?

[market analysis of chinapharma.com] recently, the Ministry of Commerce released relevant data of the pharmaceutical industry in 2017 In many sub industries, the growth rate of the business of Chinese herbal medicine processing industry and chemical API manufacturing owner is remarkable, with RMB 216.53 billion and RMB 499.17 billion respectively, up 16.7% and 14.7% year-on-year Among them, the processing industry of Chinese herbal pieces has always had a broad market in the pharmaceutical market In the past ten years, the Chinese herbal medicine industry has seized the opportunity of Chinese herbal medicine development and continuously expanded its market scale According to the data, in 2007, the market of Chinese herbal pieces was 24.2 billion yuan, and in 2016 it reached nearly 200 billion yuan, with an average annual growth rate of 26%, becoming an important part of the pharmaceutical industry However, in recent years, the alarm of quality and safety of Chinese herbal pieces has been ringing According to the notice issued by the State Food and drug administration, of the 54 unqualified drugs in 2017, more than 40% of them were Chinese herbal pieces, a total of 22 With the exposure of the negative news of Chinese herbal pieces, and the pessimism of people from all walks of life, the quality and safety of Chinese herbal pieces has been put on a huge question mark Analysis of the reasons behind, the quality of Chinese herbal pieces is mainly affected by production mode and management mode The traditional and backward production mode and unscientific management concept cause the instability of the quality of Chinese herbal pieces In addition, in addition to the disordered competition in the market, the mixture of inferior products and the exchange of fake for real, it is no doubt that the pieces are questioned It can be said that the quality problems of Chinese Herbal Pieces restrict the development of Chinese herbal medicine industry and even the whole industry It is urgent to strengthen the supervision and management of enterprises In order to break the rumor that "pieces of Chinese medicine are basically inferior products", the state has also successively issued a series of rescue measures, and strengthened the supervision of pieces of Chinese medicine market, for example: unqualified pieces of Chinese medicine are required to be recalled, some enterprises are recalled GMP certificates, some are even exposed and put on file for investigation To a certain extent, these measures give the pharmaceutical enterprises a wake-up call, urge them to improve the production mode, establish a good management concept, and produce high-quality pieces According to the 2017 annual analysis report on unqualified drug quality data released by yaozhi.com, 4106 batches of unqualified drugs and 654 batches of counterfeit products were seized in 2017 Among these unqualified drugs, there are 7 kinds, including traditional Chinese medicine (herbs and their pieces), Chinese patent medicine, chemical medicine, biological medicine, drug packaging materials, auxiliary materials and others Among them, there are 2618 batches of unqualified Chinese herbal medicines, accounting for 64%; 917 batches of unqualified Chinese patent medicines, accounting for 22%; the total proportion of Chinese herbal medicines and Chinese patent medicines reaches 86% It can be seen that its quantity is astonishing, and the disordered production of Chinese herbal pieces has not been fundamentally changed In the final analysis, supervision is one hand, the other hand lies in the production enterprise itself Based on the experience of many aspects, it is pointed out that the broken wall pieces can be used as a breakthrough to improve the quality of Chinese herbal pieces For example, Liansheng Pharmaceutical Co., Ltd is a Chinese herbal medicine enterprise which has never been detected unqualified products in 15 years Under the background of worrying about the quality of Chinese herbal pieces, the idea of making high-quality Chinese herbal pieces has arisen in the enterprise It is understood that the quality standards of traditional pieces purchased by Liansheng must be significantly higher than the National Pharmacopoeia standards Each quality standard of the company's products requires a 40% - 300% increase in the national pharmacopoeia standard In the fierce and increasingly adjusted market competition of Chinese herbal pieces, if enterprises blindly adopt the strategy of low quality and low price, it will be difficult for enterprises to move forward Therefore, only by breaking the traditional shackles and improving the quality and safety of decoction pieces, can enterprises avoid falling into a vicious circle and develop more stably.